In February this year, a total of 15 innovative pharmaceutical companies worldwide completed financing of over $50 million, with 3 Chinese pharmaceutical companies making the list

At the beginning of 2026, the global biopharmaceutical investment and financing market will continue to have a high momentum, and capital will continue to tilt towards